Efficacy of First-Line EGFR-TKI Treatment in Octogenarians with Lung Adenocarcinoma and Common EGFR Mutations.

Lin CW, Hsiao HY, Lin YC, Fang YH, Fang TP, Lin CK, Lung J, Hung MS

Open source

DOI
10.2147/cia.s605869
Published
2026
Container
Clinical interventions in aging
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2147/cia.s605869,
  title = {Efficacy of First-Line EGFR-TKI Treatment in Octogenarians with Lung Adenocarcinoma and Common EGFR Mutations.},
  author = {Lin CW and Hsiao HY and Lin YC and Fang YH and Fang TP and Lin CK and Lung J and Hung MS},
  year = {2026},
  journal = {Clinical interventions in aging},
  doi = {10.2147/cia.s605869},
  url = {https://doi.org/10.2147/cia.s605869}
}

RIS

TY  - JOUR
TI  - Efficacy of First-Line EGFR-TKI Treatment in Octogenarians with Lung Adenocarcinoma and Common EGFR Mutations.
AU  - Lin CW
AU  - Hsiao HY
AU  - Lin YC
AU  - Fang YH
AU  - Fang TP
AU  - Lin CK
AU  - Lung J
AU  - Hung MS
PY  - 2026
JO  - Clinical interventions in aging
DO  - 10.2147/cia.s605869
UR  - https://doi.org/10.2147/cia.s605869
ER  - 

APA

CW, L., HY, H., YC, L., YH, F., TP, F., CK, L., J, L., & MS, H. (2026). Efficacy of First-Line EGFR-TKI Treatment in Octogenarians with Lung Adenocarcinoma and Common EGFR Mutations.. Clinical interventions in aging. https://doi.org/10.2147/cia.s605869

Source records